As of February 2023, cancer was the therapeutic area with the largest share of biotechnology diagnostics and personalized medicine projects in development in Spain, with approximately 28 percent of the total. Biotech pipelines focusing on infections, including COVID-19, followed with a share of 16 percent of the current projects in the diagnostics and personalized medicine segment. According to a survey, around 45 percent of biotechnology companies in the European country changed their line of research to COVID-19 in 2020.
Share of biotechnology diagnostics and personalized medicine projects in development in Spain as of February 2023, by therapeutic area
Characteristic
Share of projects
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
The source does not provide a publication date. The release date corresponds to the date of access.
The source does not provide any information regarding percentage points exceeding 100 percent.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
ASEBIO. (February 21, 2023). Share of biotechnology diagnostics and personalized medicine projects in development in Spain as of February 2023, by therapeutic area [Graph]. In Statista. Retrieved July 27, 2024, from https://www.statista.com/statistics/1242431/share-of-diagnostics-and-personalized-medicine-in-development-spain/
ASEBIO. "Share of biotechnology diagnostics and personalized medicine projects in development in Spain as of February 2023, by therapeutic area." Chart. February 21, 2023. Statista. Accessed July 27, 2024. https://www.statista.com/statistics/1242431/share-of-diagnostics-and-personalized-medicine-in-development-spain/
ASEBIO. (2023). Share of biotechnology diagnostics and personalized medicine projects in development in Spain as of February 2023, by therapeutic area. Statista. Statista Inc.. Accessed: July 27, 2024. https://www.statista.com/statistics/1242431/share-of-diagnostics-and-personalized-medicine-in-development-spain/
ASEBIO. "Share of Biotechnology Diagnostics and Personalized Medicine Projects in Development in Spain as of February 2023, by Therapeutic Area." Statista, Statista Inc., 21 Feb 2023, https://www.statista.com/statistics/1242431/share-of-diagnostics-and-personalized-medicine-in-development-spain/
ASEBIO, Share of biotechnology diagnostics and personalized medicine projects in development in Spain as of February 2023, by therapeutic area Statista, https://www.statista.com/statistics/1242431/share-of-diagnostics-and-personalized-medicine-in-development-spain/ (last visited July 27, 2024)
Share of biotechnology diagnostics and personalized medicine projects in development in Spain as of February 2023, by therapeutic area [Graph], ASEBIO, February 21, 2023. [Online]. Available: https://www.statista.com/statistics/1242431/share-of-diagnostics-and-personalized-medicine-in-development-spain/
